Key result
Routine use of antithrombotic therapy in all heart failure patients lacks solid evidence to support its use without specific indications like ischemic heart disease or atrial fibrillation.
Why the study?
Does antithrombotic therapy improve outcomes in patients with heart failure?
Does antithrombotic therapy improve outcomes in patients with heart failure?
This review highlights that there is no solid evidence to support the routine use of antithrombotic agents in all heart failure patients without specific indications.
No takes yet. Share an insight, caveat, or question.
May warrant caution with routine antithrombotic therapy in HF absent specific indications; leaves open need for dedicated RCTs.
Miličić et al. (2014) conducted a review in Heart failure. Antithrombotic therapy was evaluated. Routine use of antithrombotic therapy in all heart failure patients lacks solid evidence to support its use without specific indications like ischemic heart disease or atrial fibrillation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: